BioGraphene Signs Patent License Agreement with Seoul National University and Johns Hopkins University

BioGraphene Inc. today announced that it has signed a patent license agreement with Seoul National University and Johns Hopkins University. The licensed patent is about graphene-nanostructure based pharmaceutical composition for preventing or treating neurodegenerative diseases.

This patent originated from the collaborative research between Prof. Byung Hee Hong (Founder of BioGraphene)’s group at Seoul National University and Prof. Hanseok Ko’s group at Johns Hopkins University. Under the agreement, BioGraphene will have exclusive rights in the US, EU, Japan, China and Korea for the research, development, manufacture and commercialization of patent.